Zuraiz Chaudhary
Equibles does not estimate personal net worth.
About Zuraiz Chaudhary
Zuraiz Chaudhary is recorded as CFO at Turn Therapeutics Inc. (TTRX). The newest filing on record that lists Zuraiz Chaudhary as CFO at Turn Therapeutics Inc. (TTRX) is dated October 19, 2026. The proxy statement of Turn Therapeutics Inc. reports total compensation of $1,426,754 for Zuraiz Chaudhary in fiscal 2025, including a base salary of $152,211. Disclosed compensation is on record for 2 fiscal years. Turn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Turn Therapeutics Inc. includes Bradley Burnam (CEO and Board Member), Andrew Gengos (Board Member), Arthur Golden (Board Member) and 3 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed October 19, 2026
Company network
Leadership on record at Turn Therapeutics Inc.
- Bradley Burnam CEO, Board Member
- Andrew Gengos Board Member
- Arthur Golden Board Member
- Dr. Kent Kester Board Member
- Dr. Neil Ghodadra Board Member
- Martin Dewhurst Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Turn Therapeutics Inc. (TTRX) | Interim Chief Financial Officer | $152,211 | $1,426,754 |
| 2024 | Turn Therapeutics Inc. (TTRX) | Interim Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.